The DURAClone RE panels enable sensitive detection of rare abnormal cell populations in blood or bone marrow using carefully optimized and titrated antibody combinations. Discrimination of abnormal from normal B cells during early stages of B cell development in human bone marrow can be achieved through precise assessment of B cell surface antigen expression patterns. Normal and abnormal patterns in B cells can be defined by differential densities of CD10, CD19, CD20, CD34, CD38, CD45 and CD58 expression on the surface of B cells.

  • Combination of 7 markers for sensitive detection of abnormal immature B cells, including CD10, CD19, CD20, CD34, CD38, CD45, CD58
  • Pre-formulated antibody panel in a dry unitized assay eliminating antibody cocktailing
  • 25 tests per kit including 3 compensation kits with lot matched tandem dyes

For Research Use Only. Not for use in diagnostic procedures.


Expert Panels

  • Proven marker combination to detect small populations of normal and abnormal immature B cells
  • Open channels to add drop-in markers to modify for different research questions
  • Designed for assay precision and lot-to-lot consistency


  • Eliminate time spent in titrating different antibody lots
  • Avoid waste that comes from preparing cocktail master mix
  • Simplify inventory management


Easy to Use

Explore DURAClone RE ALB Models

Content and Resources

Filter by:
Resource Type
DURAClone RE brochure - There are Events You Cannot Afford to Miss The DuraClone RE kits have been optimized to accommodate either large sample volume or high cellular concentrations to achieve high sensitivity for rare populations.

Technical Documents

Didn't find what you are looking for? For more results click here.